Trial intelligence / Profile preview

[18F]mFBG PET-CT imaging of pheochromocytoma

2024-513622-35-00Phase 2Completed

Sponsor: University Medical Center Utrecht
Start: Aug 2024
Modality: Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics, Positron Emitters → Radiopharmaceuticals, Small Molecules
Countries: 1

Overview

Phase 2, open-label, single-arm trial of florbenguane F-18 in pheochromocytoma, sponsored by University Medical Center Utrecht. Started Aug 2024; status: completed.

Drugs

florbenguane F-18

Conditions

pheochromocytoma

Beyond the preview

Go deeper on 2024-513622-35-00.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2024-513622-35-00.